Parth Shah, MD
Vascular Surgery · New Britain, CTNPI 1225224017
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,659 of the $7,846 with a category attached, or 72.1%. 17 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 38.2% of the total. Reporting peaked in 2019 at $2,623 and has fallen 71.3% since, to $752 in 2025. That places this record below the midpoint for vascular surgery clinicians in CT, where the typical reported total is $7,252.
Across 75 payments — averaging $104.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$3K
- Endologix LLC$1K
- Silk Road Medical, Inc.$808
- Medtronic$496
- Inari Medical, Inc.$465
- Bard Peripheral Vascular, Inc.$315
- plus $1K from 11 others
Across 7 payments — averaging $428.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$3K
What the payments were for
- Consulting fees$90011%
- Travel & lodging$1,28716%
- Food & beverage$5,65972%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 27 | $2,995 |
| Endologix LLC | 6 | $1,339 |
| Silk Road Medical, Inc. | 7 | $808 |
| Medtronic | 4 | $496 |
| Inari Medical, Inc. | 6 | $465 |
| Bard Peripheral Vascular, Inc. | 6 | $315 |
| Penumbra, Inc. | 2 | $287 |
| Cook Medical LLC | 2 | $238 |
| Bolton Medical Inc | 2 | $190 |
| Philips North America LLC | 4 | $187 |
| Abbott | 3 | $151 |
| Terumo Medical Corporation | 1 | $132 |
| Reflow Medical Inc | 1 | $79 |
| Lemaitre Vascular, Inc. | 1 | $78 |
| Kerecis Limited | 1 | $44 |
| Cagent Vascular Inc | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AFX$900
- ENROUTE Transcarotid Neuroprotection System$750
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$739
- ENROUTE Transcarotid Stent$414
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$387
- GORE EXCLUDER AAA Endoprosthesis$330
- FLOWTRIEVER CATHETER, S$328
- CT THROMBECTOMY SYSTEM KIT$328
- Indigo System$287
- Conformable TAG Thoracic Endoprosthesis$283
- ENDURANT IIS$266
- Blue Rhino$218
- GORE TAG Thoracic Branch Endoprosthesis$188
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$171
- ENROUTE Transcarotid Stent System$165
- ENHANCE Transcarotid Peripheral Access Kit$165
- ENROUTE 0.014 Guidewire$165
- Abre$159
- C3 Delivery System$148
- LUTONIX$146
How this compares
$7,846 in reported general payments places this provider in the 50th percentile of 82 vascular surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 39 | $41,728 |
| XareltoRivaroxaban | 45 | $39,456 |
| ClopidogrelClopidogrel Bisulfate | 211 | $2,762 |
| Atorvastatin Calcium | 113 | $1,162 |
| Cilostazol | 36 | $787 |
| Amlodipine Besylate | 24 | $156 |
| Rosuvastatin Calcium | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in New Britain
- Uwe FischerNew London$941K
- Paul GagneDarien$766K
- Naiem NassiriNew Haven$348K
- Lee GoldsteinStratford$272K
- Mohiuddin CheemaHartford$228K
- Bauer SumpioNew Haven$205K
- Javairiah FatimaDanbury$152K
- Bart MuhsOld Saybrook$66K
- Jonathan BowmanDarien$53K
- Maria LitzendorfManchester$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.